Good news on the cellular rejuvenation side of things (but its still very early… still a long way to go, and many hurdles, before Yamanaka factors are proven to improve healthspan and / or lifespan.
This is one of the most exciting areas of longevity research. In mice, we’ve seen evidence of rejuvenation in muscles, heart, brain optic nerve, skin and kidneys. Perhaps it is even more generalized.
I can definitely see this making it into (non-FDA approved) life extension clinics in the next 10 years. If it seems reasonably safe, wouldn’t you take the chance once you hit a certain age? 50? 60? 70?
Full paper added above. I’ve worked for a while in Biotech - and new clinical treatments tend to take longer to make it to market than I would have ever expected (coming from the Tech industry, where 6 months is a typical development cycle) - so I’m a little more skeptical that we’ll see anything like this in the next decade - but hey, we got the Covid vaccine out quickly, so I hope I’m wrong.
Of course the other issue is cost… I have no idea how easy or how individualized these Yamanaka factors need to be for personal therapeutics - but I just hope its affordable for most people. But yes - definitely would be interested in taking it if clinical trials show efficacy and safety.
EL PAÍS in English: Juan Carlos Izpisua: ‘Within two decades, we will be able to prevent aging’.
Izpisua is optimistic this research will yield results. “I am convinced that within two decades we will have tools that not only treat symptoms, but also can predict, prevent and treat diseases and aging through cellular rejuvenation.” He concludes: “Our end goal is to find new forms of helping everyone to slow or even reverse the processes that lead to disease.”
Izpisua is planning similar research on monkeys. In this case, his team will try to rejuvenate the animals by partially programming the Yamanaka factors with RNA messenger technology, popularly known for its use in the Pfizer-BioNTech and Moderna Covid-19 vaccines, or with chemical compounds.